Inventor

Feng Li

Inventor
Beijing, CN

Overview

42→
Patents
2003–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 42 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07KPeptides12%
C07DHeterocyclic compounds8%
C12NMicroorganisms or enzymes7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C08LCompositions of macromolecular compounds3%
C07BGeneral methods of organic chemistry2%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
PatentTitleYear
D0923609Earphones and housing assembly202111,029,011Lamp socket connector, lighting device and lighting system2021D0919981Mirror202110,772,888Solid pharmaceutical compositions containing an integrase inhibitor202010,662,249Antibodies targeting CD40 and uses thereof202010,654,937CD40 specific antibodies and uses thereof202010,654,938CD40 binding antibodies and uses thereof202010,654,939Antibodies specific to CD40 and uses thereof202010,647,776Anti-CD40 antibodies and uses thereof202010,577,424Antibodies binding VISTA and uses thereof202010,570,210Antibodies binding CD40 and uses thereof202010,442,866Antibodies binding OX40 and uses thereof201910,421,817Antibodies binding human Claudin 18.2 and uses thereof201910,400,228Truncated pullulanases, methods of production, and methods of use thereof201910,377,833Bispecific anti-HER2 antibody201910,227,342Heteroaryl compounds for kinase inhibition201910,011,587Multivalent ligands targeting VEGFR20189,834,521Choline kinase inhibitors20179,833,520Labeled, non-peptidic, multivalent integrin antagonist compounds; methods for synthesis and uses thereof20179,796,712'Heteroaryl compounds for kinase inhibition'20179,745,382'Bispecific anti-HER2 antibody'20179,649,311'Solid pharmaceutical compositions containing an integrase inhibitor'20179,604,974'Compounds as modulator of JAK-STAT pathway, methods and applications thereof'20179,573,934'Methods and compositions for the synthesis of multimerizing agents'20179,273,077'Phosphorus derivatives as kinase inhibitors'20169,024,028'Methods and compositions for the synthesis of multimerizing agents'20159,012,462'Phosphorous derivatives as kinase inhibitors'20158,912,330'Azaindole derivatives as kinase inhibitors'20148,715,755'Grain compositions containing pre-biotic isomalto-oligosaccharides and methods of making and using same'20148,629,242'Methods of inhibiting calcineurin with ApoE analogs'20148,513,347'Elastomeric compositions'20138,389,615'Elastomeric compositions comprising vinylaromatic block copolymer, polypropylene, plastomer, and low molecular weight polyolefin'20138,350,033'4-((3, 5, 6-trimethylpyrazine-2-yl) methoxyl) benzoic acid and its derivatives'20138,318,425'Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein'20128,084,207'Compositions for use in identification of papillomavirus'20117,812,085'Functionalized propylene copolymer adhesive composition'20107,645,829'Plasticized functionalized propylene copolymer adhesive composition'20107,638,151'Grain compositions containing pre-biotic isomalto-oligosaccharides and methods of making and using same'20097,537,765'Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein'20097,026,113'EIA vaccine and diagnostic'20066,585,978'EIA vaccine and diagnostic'20036,528,250'Equine infectious anemia challenge model for testing vaccines, diagnostics and treatments'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2006Based in Philadelphia, PA, US· patent location history
2010–2013Patents assigned to EXXONMOBIL CHEM PATENTS INC (4)· patent assignee history
2010–2013Based in Katy, TX, US· patent location history
2011–2021Patents assigned to LI FENG (11)· patent assignee history
2014–2019Patents assigned to ARIAD PHARMA INC (8)· patent assignee history
2014–2019Based in Winchester, MA, US· patent location history
2017–2020Patents assigned to BEIJING MABWORKS BIOTECH CO LTD (11)· patent assignee history
2017–2020Based in Beijing, CN· patent location history
2020Patents assigned to BEIJING MABRIDGE BIOPHARMACEUTICAL CO LTD (5)· patent assignee history
2021Based in Shenzhen, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BEIJING MABWORKS BIOTECH CO LTD112017–2020
LI FENGself112011–2021
ARIAD PHARMA INC82014–2019
BEIJING MABRIDGE BIOPHARMACEUTICAL CO LTD52020
EXXONMOBIL CHEM PATENTS INC42010–2013
Locations
LocationPatentsSpan
Beijing, CN112017–2020
Winchester, Massachusetts, US82014–2019
Katy, Texas, US42010–2013
Philadelphia, Pennsylvania, US32003–2006
Shenzhen, CN22021